{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:48:39Z","timestamp":1791895719843,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1053\/j.jvca.2026.06.026","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:17:49Z","timestamp":1782231469000},"page":"3616-3623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concordance of Activated Partial Thromboplastin Time and Anti\u2012Factor Xa Levels in Monitoring Heparin Therapy Among Cardiac Surgery Patients in Pre- and Postoperative Settings"],"prefix":"10.1053","volume":"40","author":[{"given":"Kavi","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh Albert","family":"Cassiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tylis Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3981-3194","authenticated-orcid":false,"given":"Pey-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2026.06.026_bib0001","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMra2104091","article-title":"Heparin resistance \u2014 Clinical perspectives and management strategies","volume":"385","author":"Levy","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2026.06.026_bib0002","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1213\/ANE.0b013e3181db7991","article-title":"The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: A prospective observational study","volume":"110","author":"Karkouti","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2026.06.026_bib0003","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jtcvs.2018.02.101","article-title":"Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery","volume":"156","author":"Oladunjoye","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.06.026_bib0004","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1002\/ehf2.14816","article-title":"Discordance between aPTT and anti-Xa in monitoring heparin anticoagulation in mechanical circulatory support","volume":"11","author":"Li","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1053\/j.jvca.2026.06.026_bib0005","first-page":"314","article-title":"Anti\u2013factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support","volume":"3","author":"Adatya","year":"2015","journal-title":"JACC: Heart Failure"},{"key":"10.1053\/j.jvca.2026.06.026_bib0006","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/1076029617741363","article-title":"Performance of anti-factor Xa versus activated partial thromboplastin time for heparin monitoring using multiple nomograms","volume":"24","author":"Whitman-Purves","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1053\/j.jvca.2026.06.026_bib0007","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1309\/AJCPS6OW6DYNOGNH","article-title":"Activated partial thromboplastin time and anti-Xa measurements in heparin monitoring: Biochemical basis for discordance","volume":"139","author":"Takemoto","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.jvca.2026.06.026_bib0008","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/1060028019835202","article-title":"Comparing anti\u2013factor Xa and activated partial thromboplastin levels for monitoring unfractionated heparin","volume":"53","author":"Wahking","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2026.06.026_bib0009","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.thromres.2021.10.010","article-title":"Comparison of clinical outcomes using activated partial thromboplastin time versus antifactor-Xa for monitoring therapeutic unfractionated heparin: A systematic review and meta-analysis","volume":"208","author":"Swayngim","year":"2021","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2026.06.026_bib0010","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1053\/j.jvca.2024.03.042","article-title":"Anti-Xa-guided anticoagulation with unfractionated heparin and thrombosis during extracorporeal membrane oxygenation support: A systematic review and meta-analysis","volume":"38","author":"Rajsic","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.06.026_bib0011","first-page":"ivad194","article-title":"Effect of cardiopulmonary bypass on coagulation factors II, VII and X in a primate model: An exploratory pilot study","volume":"37","author":"Shimoda","year":"2023","journal-title":"Interdiscip Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2026.06.026_bib0012","doi-asserted-by":"crossref","first-page":"70","DOI":"10.17305\/bjbms.2014.2266","article-title":"Changes in activated partial thromboplastin time and international normalised ratio after on-pump and off-pump surgical revascularization of the heart","volume":"14","author":"\u010ceke","year":"2014","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1053\/j.jvca.2026.06.026_bib0013","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/jcm10102158","article-title":"Evaluation of anti-activated factor X activity and activated partial thromboplastin time relations and their association with bleeding and thrombosis during veno-arterial ECMO support: A retrospective study","volume":"10","author":"Moussa","year":"2021","journal-title":"J Clin Med"},{"key":"10.1053\/j.jvca.2026.06.026_bib0014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.hrtlng.2023.05.003","article-title":"Comparison of anticoagulation monitoring strategies for adults supported on extracorporeal membrane oxygenation: A systematic review","volume":"61","author":"Sun","year":"2023","journal-title":"Heart Lung"},{"key":"10.1053\/j.jvca.2026.06.026_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/aor.14885","article-title":"Anti-factor Xa and activated partial thromboplastin time strategies for unfractionated heparin dosing after HeartMate 3 left ventricular assist device implantation","volume":"49","author":"Feng","year":"2025","journal-title":"Artif Organs"},{"key":"10.1053\/j.jvca.2026.06.026_bib0016","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jtcvs.2018.02.106","article-title":"An anticoagulation protocol for use after congenital cardiac surgery","volume":"156","author":"Nair","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.06.026_bib0017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.athoracsur.2017.10.035","article-title":"The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 Update on outcomes and quality","volume":"105","author":"D\u2019Agostino","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2026.06.026_bib0018","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.athoracsur.2008.11.011","article-title":"The Society of Thoracic Surgeons Practice Guideline Series: Blood glucose management during adult cardiac surgery","volume":"87","author":"Lazar","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2026.06.026_bib0019","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ecl.2017.10.005","article-title":"Perioperative management of hyperglycemia and diabetes in cardiac surgery patients","volume":"47","author":"Galindo","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1053\/j.jvca.2026.06.026_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-27328-8","article-title":"Dysglycaemia and the interaction of chronic and acute glycaemia with mortality post cardiac surgery","volume":"15","author":"Shi","year":"2025","journal-title":"Sci Rep"},{"key":"10.1053\/j.jvca.2026.06.026_bib0021","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clinbiochem.2008.10.012","article-title":"Epidemiological association between fasting plasma glucose and shortened APTT","volume":"42","author":"Lippi","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1053\/j.jvca.2026.06.026_bib0022","article-title":"Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.jvca.2026.06.026_bib0023","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/1756-0500-6-485","article-title":"Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus","volume":"6","author":"Sapkota","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1053\/j.jvca.2026.06.026_bib0024","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2026.06.026_bib0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1056-8727(00)00132-X","article-title":"Diabetes mellitus: A hypercoagulable state","volume":"15","author":"Carr","year":"2001","journal-title":"J Diab Complic"},{"key":"10.1053\/j.jvca.2026.06.026_bib0026","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/j.thromres.2010.05.028","article-title":"Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: A prospective observational study","volume":"126","author":"Ternstr\u00f6m","year":"2010","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2026.06.026_bib0027","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1055\/s-0043-1770096","article-title":"Factors influencing anti-Xa assays: A multicenter prospective study in critically ill and noncritically ill patients receiving unfractionated heparin","volume":"123","author":"Lasne","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.06.026_bib0028","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.thromres.2006.10.006","article-title":"Monitoring unfractionated heparin (UFH) therapy: Which anti factor Xa assay is appropriate?","volume":"120","author":"Ignjatovic","year":"2007","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2026.06.026_bib0029","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ajh.22222","article-title":"Test of the month: The chromogenic antifactor Xa assay","volume":"87","author":"Gehrie","year":"2012","journal-title":"Am J Hematol"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026005008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026005008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:03:51Z","timestamp":1791893031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077026005008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1053077026005008"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2026.06.026","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concordance of Activated Partial Thromboplastin Time and Anti\u2012Factor Xa Levels in Monitoring Heparin Therapy Among Cardiac Surgery Patients in Pre- and Postoperative Settings","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.05.069","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.06.041","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.06.046","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}